Abstract
Photodynamic therapy (PDT) is a treatment administered to patients by using photosensitizing agents. PDT systems work by combining the effect of light, photosensitizer (PS) dye, and oxygen. PDT can target cancer tissue when PS specifically localizes to the tumor cells, then with a laser, it activates by inducing a photochemical reaction which in turn can eradicate the abnormal cells and cure various types of cancer. The reactive oxygen species (ROS) initiated in the mitochondria leads to cell death, where it takes up an exogenous PS on its own. Endogenously assembled photosensitizer has been shown to cause direct tumor cell death through necrosis, apoptosis, autophagy, and vascular destruction. ROS generated by PDT also activate the immune system by minimally affecting the surrounding tissue. As a result, PDT-mediated cell death is correlated with inhibition of tumor growth. This chapter summarizes the use of natural and artificial PS compounds in different cancers, their cell death pathway mechanism, and future perspectives of PDT.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abrahamse H, Hamblin MR (2016) New photosensitizers for photodynamic therapy. Biochem J 473(4):347–364. https://doi.org/10.1042/BJ20150942
Ang JM, Riaz IB, Kamal MU, Paragh G, Zeitouni NC (2017) Photodynamic therapy and pain: a systematic review. Photodiagn Photodyn Ther 19:308–344. https://doi.org/10.1016/j.pdpdt.2017.07.002
Baskaran R, Lee J, Yang S-G (2018) Clinical development of photodynamic agents and therapeutic applications. Biomater Res 22(1):25. https://doi.org/10.1186/s40824-018-0140-z
Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, Barberi-Heyob M (2008) Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol 26(11):612–621. https://doi.org/10.1016/j.tibtech.2008.07.007
Benov L (2015) Photodynamic therapy: current status and future directions. Med Princ Pract 24(s1):14–28. https://doi.org/10.1159/000362416
Bui-Xuan N-H, Tang PM-K, Wong C-K, Fung K-P (2010) Photo-activated pheophorbide-a, an active component of Scutellaria barbata, enhances apoptosis via the suppression of ERK-mediated autophagy in the estrogen receptor-negative human breast adenocarcinoma cells MDA-MB-231. J Ethnopharmacol 131(1):95–103. https://doi.org/10.1016/j.jep.2010.06.007
Cao J, Chen H, Lu W, Wu Y, Wu X, Xia D, Zhu J (2018) Myricetin induces protective autophagy by inhibiting the phosphorylation of mTOR in HepG2 cells. Anat Rec 301(5):786–795
Choi JB, Kim JH, Lee H, Pak JN, Shim BS, Kim SH (2018) Reactive oxygen species and p53 mediated activation of p38 and caspases is critically involved in kaempferol induced apoptosis in colorectal cancer cells. J Agric Food Chem 66(38):9960–9967. https://doi.org/10.1021/acs.jafc.8b02656
Davila ML (2011) Photodynamic therapy. Gastrointest Endosc Clin 21(1):67–79
Dichiara M, Prezzavento O, Marrazzo A, Pittalà V, Salerno L, Rescifina A, Amata E (2017) Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents. Eur J Med Chem 142:459–485. https://doi.org/10.1016/j.ejmech.2017.08.070
Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3(5):380–387
Donohoe C, Senge MO, Arnaut LG, Gomes-da-Silva LC (2019) Cell death in photodynamic therapy: from oxidative stress to anti-tumor immunity. Biochim Biophys Acta Rev Cancer 1872(2):188308. https://doi.org/10.1016/j.bbcan.2019.07.003
Dougherty TJ (1974) Activated dyes as antitumor agents. J Natl Cancer Inst 52(4):1333–1336
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90(12):17. https://doi.org/10.1093/jnci/90.12.889
Dujic J, Kippenberger S, Ramirez-Bosca A, Diaz-Alperi J, Bereiter-Hahn J, Kaufmann R, Bernd A, Hofmann M (2009) Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model. Int J Cancer 124(6):1422–1428. https://doi.org/10.1002/ijc.23997
Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495–516. https://doi.org/10.1080/01926230701320337
Fleury C, Mignotte B, Vayssière JL (2002) Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84(2–3):131–141. https://doi.org/10.1016/S0300-9084(02)01369-X
Gallardo-Villagrán M, Leger DY, Liagre B, Therrien B (2019) Photosensitizers used in the photodynamic therapy of rheumatoid arthritis. Int J Mol Sci 20(13):3339. https://doi.org/10.3390/ijms20133339
Gheewala T, Skwor T, Munirathinam G (2017) Photosensitizers in prostate cancer therapy. Oncotarget 8(18):30524–30538. https://doi.org/10.18632/oncotarget.15496
Gianotti E, Martins Estevão B, Cucinotta F, Hioka N, Rizzi M, Renò F, Marchese L (2014) An efficient rose Bengal based nanoplatform for photodynamic therapy. Chem Eur J 20(35):10921–10925. https://doi.org/10.1002/chem.201404296
Hamblin MR (2020) Photodynamic therapy for cancer: what’s past is prologue. Photochem Photobiol 96(3):506–516
Hwang HS, Shin H, Han J, Na K (2018) Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy. J Pharm Investig 48(2):143–151. https://doi.org/10.1007/s40005-017-0377-x
Ji C, Yuan A, Xu L, Zhang F, Zhang S, Zhao X et al (2019) Activatable photodynamic therapy for prostate cancer by NIR dye/photosensitizer loaded albumin nanoparticles. J Biomed Nanotechnol 15(2):311–318. https://doi.org/10.1166/jbn.2019.2685
Josefsen LB, Boyle RW (2008) Photodynamic therapy: novel third-generation photosensitizers one step closer? Br J Pharmacol 154(1):1–3
Kessel D, Oleinick NL (2018) Cell death pathways associated with photodynamic therapy: an update. Photochem Photobiol 94(2):213–218
Krestyn E, Kolarova H, Bajgar R, Tomankova K (2010) Photodynamic properties of ZnTPPS4, ClAlPcS2 and ALA in human melanoma G361 cells. Toxicol in Vitro 24(1):286–291. https://doi.org/10.1016/j.tiv.2009.08.015
Kou J, Dou D, Yang L (2017) Porphyrin photosensitizers in photodynamic therapy and its applications. Oncotarget 8(46):81591
Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kędzierska E, Knap-Czop K et al (2018) Photodynamic therapy–mechanisms, photosensitizers and combinations. Biomed Pharmacother 106:1098–1107. https://doi.org/10.1016/j.biopha.2018.07.049
Longo JPF, Lozzi SP, Simioni AR, Morais PC, Tedesco AC, Azevedo RB (2009) Photodynamic therapy with aluminum-chloro-phtalocyanine induces necrosis and vascular damage in mice tongue tumors. J Photochem Photobiol B Biol 94(2):143–146. https://doi.org/10.1016/j.jphotobiol.2008.11.003
Ma J, Zhao J, Jiang L (2001) Synthesis of a novel hypocrellin B derivative and its photogeneration of semiquinone anion radical. J Photochem Photobiol B Biol 61(3):122–128. https://doi.org/10.1016/S1011-1344(01)00175-0
Mansoori B, Mohammadi A, Amin Doustvandi M, Mohammadnejad F, Kamari F, Gjerstorff MF, Baradaran B, Hamblin MR (2019) Photodynamic therapy for cancer: role of natural products. Photodiagn Photodyn Ther 26:395–404. https://doi.org/10.1016/j.pdpdt.2019.04.033
Masuelli L, Benvenuto M, Di Stefano E, Mattera R, Fantini M, De Feudis G et al (2017) Curcumin blocks autophagy and activates apoptosis of malignant mesothelioma cell lines and increases the survival of mice intraperitoneally transplanted with a malignant mesothelioma cell line. Oncotarget 8(21):34405. https://doi.org/10.18632/oncotarget.14907
Meng X, Deng J, Liu F, Guo T, Liu M, Dai P et al (2019) Triggered all-active metal organic framework: ferroptosis machinery contributes to the apoptotic photodynamic antitumor therapy. Nano Lett 19(11):7866–7876. https://doi.org/10.1021/acs.nanolett.9b02904
Mfouo-Tynga I, Abrahamse H (2015) Cell death pathways and phthalocyanine as an efficient agent for photodynamic cancer therapy. Int J Mol Sci 16(12):10228–10241. https://doi.org/10.3390/ijms160510228
Morton CA (2018) A synthesis of the world’s guidelines on photodynamic therapy for non-melanoma skin cancer. G Ital Dermatol Venereol 153(6). https://doi.org/10.23736/S0392-0488.18.05896-0
Nyman ES, Hynninen PH (2004) Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. J Photochem Photobiol B Biol 73(1–2):1–28. https://doi.org/10.1016/j.jphotobiol.2003.10.002
O’Connor AE, Gallagher WM, Byrne AT (2009) Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 85(5):1053–1074. https://doi.org/10.1111/j.1751-1097.2009.00585.x
Ormond A, Freeman H (2013) Dye sensitizers for photodynamic therapy. Materials 6(3):817–840. https://doi.org/10.3390/ma6030817
Ozog DM, Rkein AM, Fabi SG, Gold MH, Goldman MP, Lowe NJ, Martin GM, Munavalli GS (2016) Photodynamic therapy: a clinical consensus guide. Dermatol Surg 42(7):804–827. https://doi.org/10.1097/DSS.0000000000000800
Qumseya BJ, David W, Wolfsen HC (2013) Photodynamic therapy for Barrett’s esophagus and esophageal carcinoma. Clin Endosc 46(1):30. https://doi.org/10.5946/ce.2013.46.1.30
Rahman MA, Rhim H (2017) Therapeutic implication of autophagy in neurodegenerative diseases. BMB Rep 50(7):345. https://doi.org/10.5483/BMBRep.2017.50.7.069
Rahman MA, Hannan MA, Dash R, Rahman MH, Islam R, Uddin MJ et al (2021) Phytochemicals as a complement to cancer chemotherapy: pharmacological modulation of the autophagy-apoptosis pathway. Front Pharmacol 12. https://doi.org/10.3389/fphar.2021.639628
Rajendran M (2016) Quinones as photosensitizer for photodynamic therapy: ROS generation, mechanism and detection methods. Photodiagn Photodyn Ther 13:175–187. https://doi.org/10.1016/j.pdpdt.2015.07.177
Robertson CA, Evans DH, Abrahamse H (2009) Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B Biol 96(1):1–8. https://doi.org/10.1016/j.jphotobiol.2009.04.001
Sparsa A, Bellaton S, Naves T, Jauberteau MO, Bonnetblanc JM, Sol V et al (2013) Photodynamic treatment induces cell death by apoptosis or autophagy depending on the melanin content in two B16 melanoma cell lines. Oncol Rep 29(3):1196–1200
Szlasa W, Szewczyk A, Drąg-Zalesińska M, Czapor-Irzabek H, Michel O, Kiełbik A et al (2021) Mechanisms of curcumin-based photodynamic therapy and its effects in combination with electroporation: an in vitro and molecular dynamics study. Bioelectrochemistry 140:107806
Theodossiou TA, Hothersall JS, De Witte PA, Pantos A, Agostinis P (2009) The multifaceted photocytotoxic profile of hypericin. Mol Pharm 6(6):1775–1789. https://doi.org/10.1021/mp900166q
Uchoa AF, Konopko AM, Baptista MS (2015) Chlorophyllin derivatives as photosensitizers: synthesis and photodynamic properties. J Braz Chem Soc. https://doi.org/10.5935/0103-5053.20150290
Wu H, Minamide T, Yano T (2019) Role of photodynamic therapy in the treatment of esophageal cancer. Dig Endosc 31(5):508–516. https://doi.org/10.1111/den.13353
Xu L, Zhang X, Cheng W, Wang Y, Yi K, Wang Z et al (2019) Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription. Retrovirology 16(1):1–13
Ye C, Zhang C, Huang H, Yang B, Xiao G, Kong D et al (2018) The natural compound myricetin effectively represses the malignant progression of prostate cancer by inhibiting PIM1 and disrupting the PIM1/CXCR4 interaction. Cell Physiol Biochem 48(3):1230–1244
Zhang L, Ji Z, Zhang J, Yang S (2019) Photodynamic therapy enhances skin cancer chemotherapy effects through autophagy regulation. Photodiagn Photodyn Ther 28:159–165. https://doi.org/10.1016/j.pdpdt.2019.08.023
Zhenjun D, Lown JW (1990) Hypocrellins and their use in photosensitization. Photochem Photobiol 52(3):609–616. https://doi.org/10.1111/j.1751-1097.1990.tb01807.x
Zhou Z, Song J, Nie L, Chen X (2016) Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev 45(23):6597–6626. https://doi.org/10.1039/C6CS00271D
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Shah, H., Munirathinam, G. (2022). Elevating the Reactive Oxygen Species in Cancer Cells by Photodynamic Therapy. In: Chakraborti, S. (eds) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-16-1247-3_61-1
Download citation
DOI: https://doi.org/10.1007/978-981-16-1247-3_61-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-1247-3
Online ISBN: 978-981-16-1247-3
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences